Impairment of endothelium-dependent relaxation of aortas and pulmonary arteries from spontaneously hyperlipidemic mice (Apodemus sylvaticus)

Vascular Pharmacology

Volumn 47, Issue 2-3, 2007, Pages 166-173

  Ito, Kaoru M ^a   Okayasu, Misao ^a   Koshimoto, Chihiro ^b   Shinohara, Akio ^b   Asada, Yujiro ^c   Tsuchiya, Kimiyuki ^d   Sakamoto, Takumi ^b   Ito, Katsuaki ^b  

^a MINAMI KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

Author keywords

Endothelium; Hypercholesterolemia; Mice (Apodemus sylvaticus); Nitric oxide; Vascular reactivity

Indexed keywords

ACETYLCHOLINE; CHOLESTEROL; LIPID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE MODEL; ENDOTHELIUM INJURY; FEMALE; HEART RATE; HYPERLIPIDEMIA; MALE; MEAN ARTERIAL PRESSURE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; HEART RATE; HYPERLIPIDEMIAS; MALE; MICE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITROPRUSSIDE; PULMONARY ARTERY;

EID: 34447618403     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2007.06.001     Document Type: Article

References (38)

1. Bossaller C., Habib G.B., Yamamoto H., Williams C., Wells S., and Henry P.D. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J. Clin. Invest. 79 (1987) 170-174
2. Brandes R.P., Schmitz-Winnenthal F.-M., Félétou M., Gödecke A., Huang P.L., Vanhoutte P.M., Fleming I., and Busse R. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc. Natl. Acad. Sci. U. S. A. 97 (1999) 9747-9752
3. Chen G., Suzuki H., and Weston A.H. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br. J. Pharmacol. 95 (1988) 1165-1174
4. Creager M.A., Cooke J.P., Mendelsohn M.E., Gallagher S.J., Coleman S.M., Loscalzo J., and Dzau V.J. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest. 86 (1990) 228-234
5. De Gennaro Colonna V., Rigamonti A.E., Fioretti S., Bonomo S., Manfredi B., Ferrario P., Bianchi M., Berti F., Muller E.E., and Rossoni G. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in l-NAME-induced hypertensive rats. Eur. J. Pharmacol. 516 (2005) 253-259
6. d'Uscio L.V., Baker T.A., Mantilla C.B., Smith L., Weiler D., Sieck G.C., and Katusic Z.S. Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1017-1022
7. Félétou M., and Vanhoutte P.M. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br. J. Pharmacol. 93 (1988) 515-524
8. Hanafy K.A., Krumenacker J.S., and Murad F. NO, nitrotyrosine, and cyclic GMP in signal transduction. Med. Sci. Monit. 7 (2001) 801-819
9. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 100 (1997) 2153-2157
10. Huang A., Sun D., Jacobson A., Carroll M.A., Falck J.R., and Kaley G. Epoxyeicosatrienoic acids are released to mediate shear stress-dependent hyperpolarization of arteriolar smooth muscle. Circ. Res. 96 (2005) 376-383
11. Ibengwe J.K., and Suzuki H. Changes in mechanical responses of vascular smooth muscles to acetylcholine, noradrenaline and high-potassium solution in hypercholesterolemic rabbits. Br. J. Pharmacol. 87 (1986) 395-402
12. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 9265-9269
13. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., and Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92 (1993) 883-893
14. Jayakody L., Senaratne M., Thomson A., and Kappagoda T. Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ. Res. 60 (1987) 251-264
15. Jiang J., Valen G., Tokuno S., Thoren P., and Pernow J. Endothelial dysfunction in atherosclerotic mice: improved relaxation by combined supplementation with l-arginine-tetrahydrobiopterin and enhanced vasoconstriction by endothelin. Br. J. Pharmacol. 131 (2000) 1255-1261
16. Katoh M., Egashira K., Usui M., Ichiki T., Tomita H., Shimokawa H., Rakugi H., and Takeshita A. Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats. Circ. Res. 83 (1998) 743-751
17. Matsushima Y., Hayashi S., and Tachibana M. Spontaneously hyperlipidemic (SHL) mice: Japanese wild mice with apolipoprotein E deficiency. Mamm. Genome 10 (1999) 352-357
18. Moncada S., Gryglewski R., Bunting S., and Vane J.R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263 (1976) 663-665
19. Osborne J.A., Siegman M.J., Sedar A.W., Mooers S.U., and Lefer A.M. Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. Am. J. Physiol. 256 (1989) C591-C597
20. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M., and Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71 (1992) 343-353
21. Qian H., Neplioueva V., Shetty G.A., Channon K.M., and George S.E. Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation 99 (1999) 2979-2982
22. 2. Br. J. Pharmacol. 138 (2003) 1215-1220
23. Reddy K.G., Nair R.N., Sheehan H.M., and Hodgson J.M. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J. Am. Coll. Cardiol. 23 (1994) 833-843
24. Sellke F.W., Armstrong M.L., and Harrison D.G. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation 81 (1990) 1586-1593
25. Shaul P.W. Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis. J. Physiol. (Lond.) 547 (2003) 21-33
26. Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J. Mol. Cell. Cardiol. 31 (1999) 23-27
27. Shinohara A., Koshimoto C., Nakamura Y., and Tsuchiya K. Effect of aging and exogenous fat supply on the blood lipids in Apodemus hyperlipidemic (AHL) mouse. Kyushu J. Exp. Anim. 20 (2004) 21-26
28. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84 (2004) 1381-1478
29. Tsuchiya K., Yamamoto R., Asada Y., Mihara H., Sumiyoshi A., Takasaki K., Winking H., and Tsuji K. Apodemus hyperlipidemic (AHL) mouse as an experimental animal model of hypercholesterolemia. Jpn. J. Pharmacol. 58 Suppl. I (1992) 364
30. Tsujita Y., Kuroda M., Shimada Y., Tanzawa K., Arai M., Kaneko I., Tanaka M., Masuda H., Tarumi C., Watanabe Y., and Fujii S. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim. Biophys. Acta 877 (1986) 50-60
31. Verbeuren T.J., Jordaens F.H., Van Hove C.E., Van Hoydonck A.E., and Herman A.G. Release and vascular activity of endothelium-derived relaxing factor in atherosclerotic rabbit aorta. Eur. J. Pharmacol. 191 (1990) 173-184
32. Watanabe P.W. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis 36 (1980) 261-268
33. Wolfle S.E., and de Wit C. Intact endothelium-dependent dilation and conducted responses in resistance vessels of hypercholesterolemic mice in vivo. J. Vasc. Res. 42 (2005) 475-482
34. Wulf P., Rajendra K.T., Elizabeth M., Stephen G.Y., and Joseph L.W. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1569-1576
35. Yaghoubi M., Oliver-Krasinski J., Cayatte A.J., and Cohen R.A. Decreased sensitivity to nitric oxide in the aorta of severely hypercholesterolemic apolipoprotein E-deficient mice. J. Cardiovasc. Pharmacol. 36 (2000) 751-757
36. Yoshino G., Kazumi T., Kasama T., Iwai M., Iwatani I., Matsuba K., Matsushita M., and Baba S. Effect of CS-514 (pravastatin) on VLDL-triglyceride kinetics in rats. Atherosclerosis 73 (1988) 191-195
37. Zeiher A.M., Drexler H., Wollschlager H., and Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83 (1991) 391-401
38. Zhang S.H., Reddick R.L., Piedrahita J.A., and Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258 (1992) 468-471